Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma
Condition:   Soft Tissue Sarcoma Intervention:   Drug: Anrotinib hydrochloride combined with adriamycin Sponsor:   Henan Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials